{"id":"https://openalex.org/W2996627767","doi":"https://doi.org/10.1089/cmb.2019.0386","title":"Analyzing Apomorphine-Mediated Effects in a Cell Model for Parkinson's Disease with Partial Least Squares Structure Equation Modeling","display_name":"Analyzing Apomorphine-Mediated Effects in a Cell Model for Parkinson's Disease with Partial Least Squares Structure Equation Modeling","publication_year":2019,"publication_date":"2019-12-19","ids":{"openalex":"https://openalex.org/W2996627767","doi":"https://doi.org/10.1089/cmb.2019.0386","mag":"2996627767","pmid":"https://pubmed.ncbi.nlm.nih.gov/31855451"},"language":"en","primary_location":{"is_oa":false,"landing_page_url":"https://doi.org/10.1089/cmb.2019.0386","pdf_url":null,"source":{"id":"https://openalex.org/S78571599","display_name":"Journal of Computational Biology","issn_l":"1066-5277","issn":["1066-5277","1557-8666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443"],"host_organization_lineage_names":["Mary Ann Liebert, Inc."],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false},"type":"article","type_crossref":"journal-article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://lirias.kuleuven.be/bitstream/123456789/668624/2/Analyzing%20Apomorphine-Mediated%20Effects%20in%20a%20CellModel%20for%20Parkinson%e2%80%99s%20Disease%20with%20Partial%20LeastSquares%20Structure%20Equation%20Modeling","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059388535","display_name":"Daniele Pepe","orcid":"https://orcid.org/0000-0003-3354-2626"},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Daniele Pepe","raw_affiliation_strings":["Department of Oncology, KU Leuven, Leuven, Belgium."],"affiliations":[{"raw_affiliation_string":"Department of Oncology, KU Leuven, Leuven, Belgium.","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066129620","display_name":"Jin Hwan","orcid":null},"institutions":[{"id":"https://openalex.org/I201873833","display_name":"Dongyang University","ror":"https://ror.org/05v1ekw79","country_code":"KR","type":"education","lineage":["https://openalex.org/I201873833"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Jin Hwan Do","raw_affiliation_strings":["Department of Biomolecular and Chemical Engineering, DongYang University, Yeongju, Korea."],"affiliations":[{"raw_affiliation_string":"Department of Biomolecular and Chemical Engineering, DongYang University, Yeongju, Korea.","institution_ids":["https://openalex.org/I201873833"]}]}],"institution_assertions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5066129620"],"corresponding_institution_ids":["https://openalex.org/I201873833"],"apc_list":null,"apc_paid":null,"fwci":0.177,"has_fulltext":true,"fulltext_origin":"pdf","cited_by_count":1,"citation_normalized_percentile":{"value":0.450515,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":61,"max":69},"biblio":{"volume":"27","issue":"8","first_page":"1273","last_page":"1282"},"is_retracted":false,"is_paratext":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9993,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9993,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.9975,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12610","display_name":"RNA regulation and disease","score":0.9646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kegg","display_name":"KEGG","score":0.66235787},{"id":"https://openalex.org/keywords/apomorphine","display_name":"Apomorphine","score":0.5106798}],"concepts":[{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.7143321},{"id":"https://openalex.org/C152724338","wikidata":"https://www.wikidata.org/wiki/Q909442","display_name":"KEGG","level":5,"score":0.66235787},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.5106798},{"id":"https://openalex.org/C8415881","wikidata":"https://www.wikidata.org/wiki/Q6839217","display_name":"Microarray analysis techniques","level":4,"score":0.5085474},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.4635972},{"id":"https://openalex.org/C71104824","wikidata":"https://www.wikidata.org/wiki/Q1476639","display_name":"Structural equation modeling","level":2,"score":0.44647846},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.42374164},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.39863276},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38287014},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.37406695},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36499083},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.35754475},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34678343},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33634916},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33467332},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.3223362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31237248},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.28353435},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19893506},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.17743263},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.08313942},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.08140615}],"mesh":[{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D059467","descriptor_name":"Transcriptome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007024","descriptor_name":"Hypotension, Orthostatic","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007024","descriptor_name":"Hypotension, Orthostatic","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007024","descriptor_name":"Hypotension, Orthostatic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007024","descriptor_name":"Hypotension, Orthostatic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046228","descriptor_name":"Microarray Analysis","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"","qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D059467","descriptor_name":"Transcriptome","qualifier_ui":"","qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"is_oa":false,"landing_page_url":"https://doi.org/10.1089/cmb.2019.0386","pdf_url":null,"source":{"id":"https://openalex.org/S78571599","display_name":"Journal of Computational Biology","issn_l":"1066-5277","issn":["1066-5277","1557-8666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443"],"host_organization_lineage_names":["Mary Ann Liebert, Inc."],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false},{"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/668624","pdf_url":"https://lirias.kuleuven.be/bitstream/123456789/668624/2/Analyzing%20Apomorphine-Mediated%20Effects%20in%20a%20CellModel%20for%20Parkinson%e2%80%99s%20Disease%20with%20Partial%20LeastSquares%20Structure%20Equation%20Modeling","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":["KU Leuven"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false},{"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31855451","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":["National Institutes of Health"],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false}],"best_oa_location":{"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/668624","pdf_url":"https://lirias.kuleuven.be/bitstream/123456789/668624/2/Analyzing%20Apomorphine-Mediated%20Effects%20in%20a%20CellModel%20for%20Parkinson%e2%80%99s%20Disease%20with%20Partial%20LeastSquares%20Structure%20Equation%20Modeling","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":["KU Leuven"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false},"sustainable_development_goals":[{"score":0.82,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"grants":[],"datasets":[],"versions":[],"referenced_works_count":22,"referenced_works":["https://openalex.org/W1985326535","https://openalex.org/W1992103078","https://openalex.org/W1993710246","https://openalex.org/W2000190151","https://openalex.org/W2035618305","https://openalex.org/W2038963685","https://openalex.org/W2042513231","https://openalex.org/W2055661603","https://openalex.org/W2066908355","https://openalex.org/W2068416041","https://openalex.org/W2105559737","https://openalex.org/W2113285169","https://openalex.org/W2157480092","https://openalex.org/W2161669742","https://openalex.org/W2162393641","https://openalex.org/W2164601556","https://openalex.org/W2167425036","https://openalex.org/W2214630170","https://openalex.org/W2428037626","https://openalex.org/W2471122725","https://openalex.org/W2740868188","https://openalex.org/W2761745947"],"related_works":["https://openalex.org/W3119178414","https://openalex.org/W2461905030","https://openalex.org/W2418635540","https://openalex.org/W2033460309","https://openalex.org/W2025216337","https://openalex.org/W2005862793","https://openalex.org/W2005785654","https://openalex.org/W1986669422","https://openalex.org/W1974573031","https://openalex.org/W1972760188"],"abstract_inverted_index":{"Genome-wide":[0],"gene":[1],"expression":[2],"data":[3,115],"for":[4],"cell":[5,23,118,124,136,146,156],"model":[6,119,125,147,157,164],"of":[7,16,72,90,104,113,132,169,195],"Parkinson's":[8],"disease":[9,141,196],"(PD)":[10],"have":[11],"considerably":[12],"improved":[13],"our":[14],"understanding":[15],"the":[17,100],"underlying":[18,101],"molecular":[19,102],"mechanisms":[20,103],"involved":[21],"in":[22,74,92,106,134],"death":[24],"during":[25],"PD":[26,42,75,93,117,123,135,145,155],"neurodegeneration.":[27],"Apomorphine":[28],"(APOM),":[29],"a":[30,55,58],"nonselective":[31],"dopamine":[32,50],"agonist,":[33],"has":[34,66],"been":[35,67],"used":[36,127],"to":[37,46,98,128,188,192],"treat":[38],"patients":[39],"with":[40,62,161],"advanced":[41],"showing":[43],"no":[44],"response":[45],"levodopa":[47],"or":[48,200],"other":[49],"agonists.":[51],"Although":[52],"APOM":[53,73,91,105,121,133,153,189],"plays":[54],"role":[56],"as":[57,82],"free":[59],"radical":[60],"scavenger":[61],"neuroprotective":[63],"effect,":[64],"it":[65,95],"reported":[68],"that":[69,184],"long-term":[70],"use":[71,89],"treatment":[76],"brings":[77],"about":[78],"side":[79],"effects":[80,131],"such":[81],"nausea":[83],"and":[84,120,148,171,174],"orthostatic":[85],"hypotension.":[86],"For":[87],"safe":[88],"treatment,":[94],"is":[96],"crucial":[97],"understand":[99],"PD.":[107],"In":[108],"this":[109],"study,":[110],"two":[111],"groups":[112],"microarray":[114],"including":[116],"added":[122,154],"were":[126],"survey":[129],"mediation":[130],"model.":[137],"Mediation":[138],"analysis":[139],"between":[140],"genes":[142,150,186,197],"obtained":[143,151],"from":[144,152],"drug":[149,185],"was":[158],"carried":[159],"out":[160],"shortest":[162],"path":[163],"on":[165],"KEGG":[166],"(Kyoto":[167],"Encyclopedia":[168],"Genes":[170],"Genomes)":[172],"pathways":[173],"partial":[175],"least":[176],"squares":[177],"structure":[178],"equation":[179],"modeling.":[180],"Our":[181],"results":[182],"suggest":[183],"responding":[187],"might":[190],"contribute":[191],"negative":[193],"regulation":[194],"by":[198],"direct":[199],"indirect":[201],"ways.":[202]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2996627767","counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2025-01-19T20:01:51.902661","created_date":"2019-12-26"}